29562902Mambetsariev I, Vora L, Yu KW, Salgia RBMC cancerErbB Receptors; Mutation; NeoplasmsAcrylamides; Alleles; Amino Acid Substitution; Aniline Compounds; Antineoplastic Agents; Biomarkers, Tumor; Biopsy; Carcinoma, Non-Small-Cell Lung; Humans; Liquid Biopsy; Lung Neoplasms; Magnetic Resonance Angiography; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Tomography, X-Ray ComputedEffective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy. BMC Cancer. 2018 03 21; 18(1):314.BMC Cancer2018-03-21T00:00:002018Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000178Chemicals & Drugs22300.98606AcrylamidesD000483Genes & Molecular Sequences29311270.757225AllelesD000970Chemicals & Drugs40723510.435494Antineoplastic AgentsD000814Chemicals & Drugs28490.972594Aniline CompoundsD001706Procedures39411600.740759BiopsyD002289Disorders15810730.519185Carcinoma, Non-Small-Cell LungAuthorship 12143740.6586910.6586911authors10.2520has subject areaD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD009154Physiology70239520.442682MutationD008175Disorders32822600.404557Lung NeoplasmsD010879Chemicals & Drugs1102720.858236PiperazinesD006801Living Beings2262862810.130064HumansD014057Procedures54325940.473525Tomography, X-Ray ComputedD014408Chemicals & Drugs32614610.548135Biomarkers, TumorD008297Physiology1931408600.201635MaleD019943PhysiologyProcedures1723390.894091Amino Acid SubstitutionD00007389022330.972507Liquid BiopsyD066246Chemicals & Drugs1494850.779557ErbB ReceptorsD009369Disorders55628890.338498NeoplasmsD018810Procedures762610.810758Magnetic Resonance AngiographyD047428Chemicals & Drugs2065890.714226Protein Kinase InhibitorsMedicineUniversity of ChicagoRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professor